Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1096 of 5804
-
New chemo combo tested for returning lymphoma
Disease control Not yet recruitingThis study was a multicenter, open, randomized controlled, phase II clinical study. Is expected in 70 cases of late relapsed diffuse large B cell lymphoma, were randomly assigned to receive mitoxantrone liposomes modified R - MINE plan or R - GemOx treatment. Each cycle was 3 wee…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Simple DNA test could predict bladder cancer recurrence
Diagnosis Recruiting nowBladder cancer is a highly heterogeneous malignancy characterized by frequent genetic alterations that are closely associated with disease progression, recurrence risk, and treatment response. However, existing mutation detection approaches are often limited by high cost, complex…
Sponsor: Zhilong Dong • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo aims to tame deadly fat levels in the blood
Disease control Recruiting nowPhase II clinical trial evaluating the efficacy and safety of HRS-7249 and SHR-1918 in patients with severe hypertriglyceridemia at high risk of acute pancreatitis
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill aims to smooth out Parkinson's motor swings
Symptom relief Recruiting nowThis is a Phase 2 study in people with Parkinson's disease who experience motor fluctuations while taking levodopa. The study will evaluate how effective two different doses of the study drug AP-472 are when added to levodopa treatment, compared with a placebo. The study will la…
Phase: PHASE2 • Sponsor: Appello Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New polymer implant aims to stop aortic dissection from worsening
Disease control Recruiting nowTo determine the safety and feasibility of the investigational product to reduce aortic dissection false lumen perfusion.
Phase: NA • Sponsor: Shape Memory Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Shingrix vaccine under the microscope: can it shield patients on Immune-Weakening drugs?
Knowledge-focused Recruiting nowVaricella-zoster virus (VZV) is one of the eight herpesviruses that infect humans by manifesting as varicella. After primary infection VZV remains latent for life. In 30% of individuals the virus reactivates causing a secondary infection, herpes zoster (HZ). The most common compl…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New balloon coated with drug could keep airways open longer
Disease control Recruiting nowThe OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of ca…
Phase: NA • Sponsor: Airiver Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cancer drug BI 3810944 enters first human tests
Disease control Recruiting nowThis study is open to adults with advanced cancer (solid tumours) for whom previous treatment was not successful, or no treatment exists. The study tests different doses of BI 3810944 to find out which doses they can tolerate. Another purpose is to identify the most suitable dose…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Brain zaps for smokers: new trial tests quick quit method
Disease control Recruiting nowThe goal of this clinical trial is to examine whether a 5-day course of bilateral accelerated deep transcranial magnetic stimulation (aTMS) is a feasible treatment to help adults (18-65) with Tobacco Use Disorder to quit smoking. This study aims to enroll 30-40 participants and w…
Phase: PHASE2 • Sponsor: Waypoint Centre for Mental Health Care • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to block Cancer's growth signals
Disease control Not yet recruitingGH55 Capsule is a novel, highly selective small molecule dual mechanism ERK1/2 inhibitor. GH21 Capsule is a potent, orally active human SHP2 allosteric inhibitor. The combination of an ERK1/2 inhibitor and an SHP2 inhibitor achieves a dual effect: synergistic upstream and downstr…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could your own blood ease chronic shoulder pain?
Symptom relief Recruiting nowThe experimental group will receive intralesional injections of platelet-rich plasma, evaluating its ability to relieve pain and provide sustained improvement through biological modulation of the joint and tendon environment. In contrast, the control group will be treated with a …
Phase: PHASE3 • Sponsor: Biobizkaia Health Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New drug IDE034 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis is a Phase 1a/1b, open-label, multicenter dose escalation and dose expansion clinical study to evaluate the safety, PK, immunogenicity and preliminary efficacy of IDE034 in participants with locally advanced/metastatic solid tumor types that express B7-H3 and PTK7.
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Weight-Loss drug stop colon cancer before it starts?
Prevention Recruiting nowThis research study is an open-label Phase 1 Exploratory/Pilot clinical trial to measure the effects of the incretin mimetic, tirzepatide, on tissue, urine, blood, and microbiome biomarkers associated with colorectal cancer risk and to understand the feasibility of this precision…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New diabetes drug HDM1005 enters final testing phase
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled , phase 3 clinical trial aimed at evaluating the efficacy and safety of HDM1005 versus placebo in subjects with T2DM inadequate glycemic control with diet and exercise alone. A total of 240 subjects will b…
Phase: PHASE3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Vitamin B12 trial aims to stop Chemo's painful side effect
Prevention Recruiting nowSome patients receiving taxane-based chemotherapy experience numbness, tingling, or pain in their hands and feet, known as chemotherapy-induced peripheral neuropathy (CIPN). This study aims to find out whether oral mecobalamin can prevent or reduce CIPN. Participants will be assi…
Phase: PHASE3 • Sponsor: Qinghai Red Cross Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
New pain drug aims to get your gut moving again after surgery
Symptom relief Not yet recruitingTitle: Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery: A Multicenter, Randomized, Controlled Trial The goal of this clinical trial is to evaluate the effectiveness and safety of tegileridine, a biased μ-opioid receptor agonist, for patient-c…
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New antibody drug ADCX-020 enters first human trials for advanced cancers
Disease control Recruiting nowThe purpose of this first-in-human study is to explore the safety, pharmacokinetics and effects of the study drug ADCX-020 in patients with advanced and metastatic solid tumors. ADCX-020 is an investigational anticancer therapy called antibody drug conjugate. This study is set u…
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo aims to outsmart relapsed lung cancer
Disease control Recruiting nowRandomized phase 2, multicenter, biomarker directed clinical trial with a safety lead-in to assess the efficacy of Stenoparib plus Temozolomide (TMZ) in relapsed Small Cell Lung Cancer patients. Participants will receive either a combination of oral Stenoparib at the highest tole…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brain boost: exercise and zaps may sharpen mind in tough schizophrenia cases
Symptom relief Not yet recruitingCognitive impairment is a major determinant of disability in schizophrenia. Aerobic exercise improves global cognition in schizophrenia, particularly working memory and attention/vigilance. Transcranial direct current stimulation (tDCS) targeting frontal regions has shown promise…
Phase: NA • Sponsor: Kit Wa Chan • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
One-Day HPV test and treatment could cut cervical cancer in women with HIV
Disease control Recruiting nowThis study aims to conduct a randomized controlled trial to evaluate the effectiveness of same-day HPV-based screen and treat among women living with HIV (WLH) in La Romana, Dominican Republic. With cervical cancer being a leading cause of cancer-related deaths in women living wi…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC